Cover Image

Abandoning Non Invasive Risk Stratification in WPW: There Is no Such Thing as a Free Lunch

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Andrew Krumerman
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Journal of Cardiovascular Electrophysiology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Methodological Limitations in the Assessment of Intermittent Ventricular Pre‐Excitation in WPW Syndrome
by: Ayesha Abbas, et al.
Published: (2025)

Letter to the Editor: Anticoagulation Risk Stratification and Methodological Considerations in Immediate Mobilization After Atrial Fibrillation Ablation
by: XiRui Yang
Published: (2025)

The Resynchronization Effect in Left Bundle Branch Pacing Can be Evaluated Non‐Invasively With the Implementation of Lead V8
by: Vadivelu Ramalingam, et al.
Published: (2026)

Risk Prediction in Non‐Ischemic Cardiomyoapthy
by: Jay A. Montgomery, et al.
Published: (2024)

Myocardial Fibrosis Distribution and Electrical Activation Patterns in Left Bundle Branch Block: Integration of Non‐Invasive Electrocardiographic Activation Mapping and Cardiovascular Magnetic Resonance Imaging Late Gadolinium Enhancement
by: Elena Rimskaya, et al.
Published: (2025)

Microembolic Signals During Atrial Fibrillation Ablation: Is the Thing That Catches the Eye the Real Villain? Or Is It Innocent and Insignificant?
by: Koichiro Ejima
Published: (2025)

An Unpredictable Atrioventricular Accessory Pathway: Low‐Risk or High‐Risk?
by: Tommaso Sciarretta, et al.
Published: (2025)

Cannabis Use and the Risk of Arrhythmias: Insights From a Large Retrospective Multicenter Analysis
by: Juan Vargas, et al.
Published: (2025)

Risk stratification for ventricular tachyarrhythmia in patients with nonischemic cardiomyopathy
by: Ido Goldenberg, et al.
Published: (2024)

A Novel Risk Score for Predicting the Difficulty in Leadless Pacemaker Implantation
by: Naruya Ishizue, et al.
Published: (2026)

Risk of Cardiovascular Implantable Electronic Device Infection in Patients With Cardiac Sarcoidosis
by: Chukwuka Ibecheozor, et al.
Published: (2026)

Risk of Cardiac Implantable Electronic Device Infection With Temporary Tunneled Hemodialysis Catheters
by: Jingwen Huang, et al.
Published: (2025)

Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation
by: Ghee Kheng Lim, et al.
Published: (2025)

The Question Is Not “Paroxysmal or Persistent?” But “PV‐Dependent or Non‐PV Dependent?”
by: Kentaro Yoshida
Published: (2025)

Commentary on “Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
by: Pouya Tayebi, et al.
Published: (2025)

Catheter Ablation in Atrial Fibrillation and Obstructive Sleep Apnea: From Rhythm Control to Risk Reduction
by: Siddharth Agarwal, et al.
Published: (2025)

Letter to the Editor: Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation
by: Syed Ali Raza Zaidi, et al.
Published: (2025)

Post‐TAVR conduction abnormalities leading to permanent pacemaker implantation: Risk factors, prevention, and management
by: Rachad Ghazal, et al.
Published: (2024)

Accessory Pathway Antegrade Electrophysiologic Features Among Wolff–Parkinson–White Patients: The Risk in Relation to the Location
by: Salah Atta, et al.
Published: (2025)

Response to Letter Regarding “Sodium–Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
by: Xuan Ci Mee, et al.
Published: (2025)

Extravascular Cardioverter‐Defibrillator for Primary Prevention in an 11‐Year‐Old Boy With Phenotype of High Risk Overlapping Cardiomyopathies
by: M. Sterliński, et al.
Published: (2026)

Patients Experiencing Unsuccessful Defibrillation From Implantable Cardiac Devices Remain at Elevated Risk Despite Procedural Management
by: Nathaniel Christian‐Miller, et al.
Published: (2026)

Response to Letter to the Editor Concerning the Article “Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
by: Ramzi Ibrahim, et al.
Published: (2025)

Association of Risk Factors and Cardiac Outcomes in Patients With Primary Prevention of Sudden Cardiac Death: HINODE Study Sub Analysis
by: Hiroshi Hayashi, et al.
Published: (2025)

The Predictive Value of Real‐World Cardiologist Performance (RWCP) Score in Atrial Fibrillation Recurrence Risk After Radiofrequency Ablation
by: Yangyang Wang, et al.
Published: (2025)

Revisiting First‐Line VoM Ablation in PeAF: Primum Non Nocere Matters
by: Cem Çöteli
Published: (2025)

Periprocedural Risk Factors for Early Incident Acute Heart Failure After Catheter Ablation of Atrial Fibrillation: Findings From the CLAPHAF Study
by: Parin J. Patel, et al.
Published: (2025)

Exploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non‐Actionable Alerts and Assessing Clinical Outcomes
by: Mohamed A. Mostafa, et al.
Published: (2025)

Impact of Right Superior Pulmonary Vein Anatomy and 31‐mm Cryoballoon Use on the Risk of Phrenic Nerve Injury During Cryoablation for Atrial Fibrillation
by: Sadahiro Murota, et al.
Published: (2026)

Isoproterenol for Unmasking Dormant Conduction and Non‐Pulmonary Vein Triggers During Atrial Fibrillation Ablation: Prospective Multicenter Study
by: Saumil R. Oza, et al.
Published: (2025)

Letter to Editor: Periprocedural Risk Factors for Early Incident Acute Heart Failure After Catheter Ablation of Atrial Fibrillation: Findings From the CLAPHAF Study
by: Muhammad Ahmad, et al.
Published: (2025)

Contemporary Study of New Onset Atrial Fibrillation Treatment Strategies at a Large Academic Tertiary Care Center
by: Tarek Zghaib, et al.
Published: (2025)

Near‐Zero‐Fluoroscopy Ablation of Atrial Fibrillation Without ICE or Non‐Fluoroscopic Tracking Systems: Findings From the SHORT LOOK Registry
by: Martin Borlich, et al.
Published: (2025)

Feasibility and Clinical Efficacy of Focal Pulsed Field Ablation in Patients With Non‐Pulmonary Vein Triggered Atrial Arrhythmia From the Superior Caval Vein
by: Ahmad Keelani, et al.
Published: (2024)

Safety and Efficacy of a Novel Sealant‐Based Vascular Closure Device Following Electrophysiology Procedures: ReliaSeal Trial
by: John Summers, et al.
Published: (2025)

Catheter Ablation Versus Medical Therapy as First‐Line Treatment for Ventricular Electrical Storm: A Systematic Review and Meta‐Analysis
by: Khalid Sawalha, et al.
Published: (2025)

Evidence of Late Septal Coronary Involvement After Bipolar Radiofrequency Ablation in a Patient With Lamin A/C Cardiomyopathy
by: Alaa A. Shalaby, et al.
Published: (2025)

Adding Non‐Occlusive Cryoballoon Ablation in Case of Ostial‐Level Pulmonary Vein Isolation or Carina Sparing Does Not Improve 1‐Year Outcome After Cryoballoon Ablation (the NOCA‐AF Study)
by: A. Strazdas, et al.
Published: (2025)

Prospective Trial of Radiofrequency Catheter Ablation of High Dominant Frequencies After Pulmonary Vein Isolation in Non‐Paroxysmal Atrial Fibrillation (PAD‐AF Trial): A Multicenter, Randomized Clinical Trial
by: Koji Kumagai, et al.
Published: (2026)

Association between proactive esophageal cooling and increased lab throughput
by: William Zagrodzky, et al.
Published: (2024)